In KRASMUT tumors-derived tumor-specific CTLs, blocking p65 nuclear translocation using NF-κB inhibitors BAY or JSH-23 abolished the AICD reduction upon circATXN7 silencing (Supplementary Fig. 9N). This evidence concerns the gene NFKB1 and neoplasm.